论文部分内容阅读
作者查阅了治疗青光眼的文献,包括药膜释放系统,噻吗心安以及药物小梁切除等。此外,作者还简单的综述了抗病毒治疗的近况与人工泪液治疗眼干燥症的发展。一、青光眼的治疗 (一)合成药膜释放系统:青光眼的长期控制需要病人严格遵守局部用药制度,许多病人不能很好配合,这对于控制该病是不利的。规则、间隔的给药是“一级释放系统(first-order delivery system)”,开始吸收的剂量大而后逐渐下降,直到再次给药。较理想的情况是“零级释放系统(Zero-order delivery system)”,其药物的释放
The authors reviewed the literature for the treatment of glaucoma, including the drug release system, timolol, and trabeculectomy. In addition, the author also briefly reviewed the current status of antiviral therapy and artificial tears in the treatment of xerophthalmia. First, the treatment of glaucoma (A) synthetic membrane release system: The long-term control of glaucoma requires patients to strictly abide by the local drug system, many patients can not be well coordinated, which is detrimental to the control of the disease. Regular, interval dosing is a “first-order delivery system” and begins with a large dose of absorption and then decreases gradually until further administration. A more desirable case is the “zero-order delivery system,” the release of the drug